EyePoint Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 3, 2021GlobeNewsWire • 10/27/21
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual MeetingGlobeNewsWire • 10/12/21
EyePoint Sets its Sights on Developing Treatments Improving the Lives of Eye Disease SufferersBenzinga • 09/30/21
EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual MeetingGlobeNewsWire • 09/17/21
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 08/04/21
EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory BoardGlobeNewsWire • 08/02/21
EyePoint Pharmaceuticals (EYPT) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/28/21
EyePoint Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 4, 2021GlobeNewsWire • 07/28/21
EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®GlobeNewsWire • 07/20/21
EyePoint Pharmaceuticals Announces New Category III CPT Code for DEXYCU® Intraocular Suspension, Approved by the American Medical AssociationGlobeNewsWire • 07/01/21
EyePoint Pharmaceuticals to Participate in Fireside Chat at the Jefferies Virtual Healthcare ConferenceGlobeNewsWire • 05/26/21
EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMDGlobeNewsWire • 05/25/21
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/05/21
EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 05/05/21
Will EyePoint Pharmaceuticals (EYPT) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/28/21
EyePoint Pharmaceuticals to Report First Quarter 2021 Financial Results and Discuss Recent Corporate Developments on May 5, 2021GlobeNewsWire • 04/28/21
EyePoint Pharmaceuticals' (EYPT) CEO Nancy Lurker on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/04/21
EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/04/21